Do Histogen Inc. (HSTO) beta value of 1.12 signposts another twist? – Invest Chronicle

Do Histogen Inc. (HSTO) beta value of 1.12 signposts another twist?

For the readers interested in the stock health of Histogen Inc. (HSTO). It is currently valued at $1.72. When the transactions were called off in the previous session, Stock hit the highs of $1.95, after setting-off with the price of $1.75. Company’s stock value dipped to $1.61 during the trading on the day. When the trading was stopped its value was $1.68.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Recently in News on January 19, 2021, Histogen Reports FDA Clinical Hold for Planned Phase 1/2 Trial of HST-003 for Knee Cartilage Regeneration. Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing potential first-in-class restorative therapeutics that ignite the body’s natural process to repair and maintain healthy biological function today announced that the U.S. Food and Drug Administration (FDA) has verbally notified the company that it has additional questions about the company’s Investigational New Drug (“IND”) application package for the planned Phase 1/2 clinical trial of HST-003, which is intended to evaluate the safety and efficacy of human extracellular matrix (hECM:HST-003) implanted within microfracture interstices and the cartilage defect in the knee to regenerate hyaline cartilage in combination with a microfracture procedure. You can read further details here

A Backdoor Way To Profit From Today’s Crypto Bull Market

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .


Histogen Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $1.9500 on 02/10/21, with the lowest value was $0.7700 for the same time period, recorded on 01/04/21.

Histogen Inc. (HSTO) full year performance was -64.17%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Histogen Inc. shares are logging -77.07% during the 52-week period from high price, and 129.64% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.75 and $7.50.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 6832014 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Histogen Inc. (HSTO) recorded performance in the market was 126.91%, having the revenues showcasing -2.27% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 48.80M, as it employees total of 5 workers.

Market experts do have their say about Histogen Inc. (HSTO)

During the last month, 0 analysts gave the Histogen Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on, the moving average of the company in the 100-day period was set at 1.4534, with a change in the price was noted -0.0200. In a similar fashion, Histogen Inc. posted a movement of -1.15% for the period of last 100 days, recording 1,431,189 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for HSTO is recording 0.07 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.07.

Technical breakdown of Histogen Inc. (HSTO)

Raw Stochastic average of Histogen Inc. in the period of last 50 days is set at 80.85%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 77.67%. In the last 20 days, the company’s Stochastic %K was 84.45% and its Stochastic %D was recorded 79.28%.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Bearing in mind the latest performance of Histogen Inc., several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 126.91%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -40.28%, alongside a downfall of -64.17% for the period of the last 12 months. The shares increased approximately by 35.43% in the 7-day charts and went down by 86.35% in the period of the last 30 days. Common stock shares were lifted by -2.27% during last recorded quarter.

Leave a Comment

Your email address will not be published. Required fields are marked *

Get The Best Stocks To Trade Every Day!

Join now to get the pre-market morning brief 100% free

We do not sell or share your information with anyone.